why are glp 1 drugs so expensive GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity FDA's compounded GLP-1 limits will

Segment Analysis GLP-1 Receptor Agonist Market Analysis by Drug Based on FMI's GLP-1 receptor agonist market report, demand for exenatide is estimated to lead the drug segment, capturing 24.4% of the market share in 2025

[14] The injection is generally well tolerated

In November 2025, Novo Nordisk and Eli Lilly both reached similar deals with the Trump administration to sell the lowest dose of oral GLP-1 medications for $149 per month out of pocket

Injectable BPC-157 Using BPC-157 as a subcutaneous injection is our preferred route for tendon, ligament, muscle, and post-surgical healing

"Although some of these substances may not be legally restricted in ordinary consumer contexts, we have proactively adopted stricter standards to define operational boundaries and our compliance efforts go beyond passive adherence and minimum legal requirements," the company said in a statement